0001773751-24-000057.txt : 20240307 0001773751-24-000057.hdr.sgml : 20240307 20240307201058 ACCESSION NUMBER: 0001773751-24-000057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240305 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baird Melissa CENTRAL INDEX KEY: 0001837815 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 24732021 MAIL ADDRESS: STREET 1: 2269 CHESTNUT STREET, #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 4 1 wk-form4_1709860250.xml FORM 4 X0508 4 2024-03-05 0 0001773751 Hims & Hers Health, Inc. HIMS 0001837815 Baird Melissa 2269 CHESTNUT STREET, #523 SAN FRANCISCO CA 94123 0 1 0 0 Chief Operating Officer 1 Class A Common Stock 2024-03-05 4 M 0 6715 0.40 A 514180 D Class A Common Stock 2024-03-05 4 M 0 5036 0.40 A 519216 D Class A Common Stock 2024-03-05 4 S 0 6715 14.2158 D 512501 D Class A Common Stock 2024-03-05 4 S 0 5036 14.2183 D 507465 D Class A Common Stock 2024-03-06 4 M 0 5036 0.40 A 512501 D Class A Common Stock 2024-03-06 4 M 0 6715 0.40 A 519216 D Class A Common Stock 2024-03-06 4 S 0 5036 13.9881 D 514180 D Class A Common Stock 2024-03-06 4 S 0 6715 13.986 D 507465 D Class A Common Stock 2024-03-07 4 M 0 5036 0.40 A 512501 D Class A Common Stock 2024-03-07 4 M 0 6715 0.40 A 519216 D Class A Common Stock 2024-03-07 4 S 0 6715 14.358 D 512501 D Class A Common Stock 2024-03-07 4 S 0 5036 14.3507 D 507465 D Stock Option (right to buy) 0.40 2024-03-05 4 M 0 6715 0 D 2028-03-28 Class A Common Stock 6715 803949 D Stock Option (right to buy) 0.40 2024-03-05 4 M 0 5036 0 D 2028-03-28 Class A Common Stock 5036 798913 D Stock Option (right to buy) 0.40 2024-03-06 4 M 0 5036 0 D 2028-03-28 Class A Common Stock 5036 793877 D Stock Option (right to buy) 0.40 2024-03-06 4 M 0 6715 0 D 2028-03-28 Class A Common Stock 6715 787162 D Stock Option (right to buy) 0.40 2024-03-07 4 M 0 6715 0 D 2028-03-28 Class A Common Stock 6715 780447 D Stock Option (right to buy) 0.40 2024-03-07 4 M 0 5036 0 D 2028-03-28 Class A Common Stock 5036 775411 D The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.96 - $14.47. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.99 - $14.475. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.55- $14.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.72 - $14.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.13- $14.66. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.08 - $14.54. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. /s/ Alexandra Cotter Wilkins, Attorney-in-Fact 2024-03-07